Chronic Ataxic Neuropathy with Disialosyl Antibodies (CANDA) is a rare, immune-mediated peripheral neuropathy characterized by progressive problems with coordination (ataxia) and sensory loss in the limbs. In CANDA, the body’s immune system mistakenly targets specific sugar molecules (disialosyl moieties) on nerve cell membranes, leading to nerve damage. The term “disialosyl” refers to two sialic acid residues linked together, a structure found on ganglioside GD1b and related molecules in peripheral nerves. When autoantibodies bind these disialosyl groups, they trigger inflammation and disrupt normal nerve conduction, resulting in the hallmark symptoms of CANDA.
Chronic Ataxic Neuropathy with Disialosyl Antibodies (also known as CANDA or CANOMAD when accompanied by ophthalmoplegia and monoclonal IgM paraprotein) is a rare, immune-mediated sensory ataxic neuropathy. Patients typically present in mid-adulthood (median age ~56 years) with slowly progressive gait ataxia, loss of proprioception, sensory disturbances, and often ocular motor involvement. The hallmark laboratory finding is an IgM monoclonal protein directed against disialosyl ganglioside epitopes (e.g., GD1b, GD3, GT1b), which binds to peripheral nerve structures—particularly dorsal root ganglia and myelinated fibers—and induces neural injury via complement activation and direct antibody-mediated toxicity pubmed.ncbi.nlm.nih.govrarediseases.org.
Over weeks to months, patients notice worsening balance, unsteady gait, and numbness or tingling in their hands and feet. Unlike some acute neuropathies, CANDA typically follows a chronic, stepwise progression, with periods of relative stability punctuated by slow declines. Early recognition and treatment with immunotherapies can slow progression and improve quality of life, making awareness of this condition crucial for neurologists, general practitioners, and rehabilitation teams.
Types of CANDA
Although CANDA is itself a defined syndrome, subtle variations can occur based on the specific antibody profile and clinical presentation. Recognizing these types helps guide testing and therapy.
Classic GD1b-Antibody CANDA
Patients have high titers of anti-GD1b IgM or IgG antibodies. They present with predominant sensory ataxia, often with minimal weakness.Mixed Ganglioside CANDA
Autoantibodies target GD1b plus GM1 or GQ1b, leading to mixed sensory and motor involvement and occasional cranial nerve signs.Pure Small-Fiber CANDA
Antibodies primarily affect small unmyelinated fibers; patients experience burning pain and autonomic symptoms such as sweating changes, with milder ataxia.Motor-Dominant Variant
Though rare, some patients develop more pronounced muscle weakness than sensory loss, mimicking other chronic inflammatory demyelinating neuropathies.Familial Predisposition Variant
In a minority of cases, family members share HLA haplotypes associated with disialosyl antibody production, suggesting a genetic susceptibility.
Causes of CANDA
While the exact trigger for autoantibody production in CANDA is not fully understood, multiple factors can contribute:
Molecular Mimicry after Infection
Certain bacterial or viral surface molecules resemble disialosyl structures, leading to cross-reactive antibodies.Guillain–Barré Syndrome Transition
A small subset of patients with GBS evolves into chronic CANDA when anti-disialosyl antibodies persist.Vaccination-Related Immune Activation
Rarely, vaccines trigger an immune response that includes disialosyl-reactive antibodies.Paraneoplastic Syndromes
Some cancers express disialosyl-rich gangliosides, provoking autoimmunity.Chronic Infections
Hepatitis C or HIV may dysregulate immune tolerance, facilitating autoantibody formation.Genetic Predisposition
Specific HLA alleles increase the risk of producing disialosyl antibodies.Gut Microbiome Alterations
Dysbiosis can shift immune balance toward autoimmunity.Environmental Toxins
Exposure to heavy metals or organic solvents may damage peripheral nerves and expose antigenic targets.Idiopathic Immune Dysregulation
In many patients, no clear trigger is identified, and spontaneous breakdown of self-tolerance occurs.Drug-Induced Autoimmunity
Certain medications (e.g., checkpoint inhibitors) can unmask neuronal antigens.Post-Surgical Immune Changes
Major surgery can transiently alter immune surveillance, leading to autoantibody production.Age-Related Immunosenescence
Aging immune systems may more readily produce autoreactive clones.Chronic Stress
Prolonged physiological stress can impair regulatory T-cell function.Hormonal Fluctuations
Changes in estrogen or cortisol levels influence autoantibody generation.Coexisting Autoimmune Diseases
Patients with lupus or rheumatoid arthritis have a higher risk.Vitamin D Deficiency
Low vitamin D levels correlate with other autoimmune neuropathies.Occupational Chemical Exposure
Long-term exposure to pesticides or solvents may be implicated.Radiation Therapy
Radiation to thoracic or abdominal regions can release neuronal antigens.Traumatic Nerve Injury
Nerve trauma may expose disialosyl epitopes.Unknown Idiopathic Factors
Up to 30% of cases have no identifiable cause despite extensive evaluation.
Symptoms of CANDA
Symptoms arise from damage to sensory fibers, often beginning in the feet and spreading proximally:
Gait Unsteadiness
A feeling of wobbling when walking, worsened in low light.Hand Clumsiness
Difficulty buttoning shirts or picking up small objects.Vibration Sense Loss
Reduced perception of a tuning fork placed on bones.Proprioceptive Deficits
Impaired awareness of limb position, leading to missteps.Numbness and Tingling
“Pins and needles” in hands and feet, often worse at night.Balance Problems
Difficulty standing on one foot or heel-to-toe.Muscle Cramps
Painful spasms in calves or thighs.Hyporeflexia
Diminished or absent deep tendon reflexes at ankles and knees.Sensory Ataxia
Ataxia more pronounced when eyes are closed (positive Romberg sign).Orthostatic Dizziness
Lightheadedness upon standing, due to autonomic involvement.Neuropathic Pain
Burning or shooting pains, often in stocking–glove distribution.Fine Motor Impairment
Tremor or irregular movements during precise tasks.Distal Weakness
Mild weakness in feet or hands, secondary to sensory loss.Gastrointestinal Dysmotility
Constipation or diarrhea from autonomic fiber involvement.Sweating Abnormalities
Reduced or excessive sweating in affected limbs.Urinary Dysfunction
In some cases, urgency or retention from autonomic damage.Slurred Speech
Rarely, involvement of facial sensory fibers affects articulation.Fatigue
Generalized tiredness due to chronic disease burden.Visual Disturbances
Blurred vision if cranial nerves are involved.Sleep Disturbances
Nighttime pain or tingling disrupts rest.
Diagnostic Tests for CANDA
Diagnosis combines clinical evaluation, specialized tests, and antibody assays. Below are 40 key tests, grouped by category.
A. Physical Exam
Observation of Gait
Watch the patient walk to identify ataxic patterns and widened stance.Romberg Test
Assess balance with feet together, eyes open then closed; increased sway suggests sensory ataxia.Heel-to-Shin Test
Patient slides heel down opposite shin; overshoot or wavering indicates ataxia.Finger-to-Nose Test
Tests upper limb coordination; dysmetria suggests cerebellar vs. sensory origin.Tendon Reflexes
Tap Achilles and patellar tendons; reduced reflexes support peripheral neuropathy.Vibration Sense
Use a 128 Hz tuning fork on bony prominences; decreased perception indicates large fiber loss.Proprioception Testing
Move toe or finger up/down; inability to identify position indicates sensory loss.Sensory Pinprick
Lightly prick skin to assess pain sensation; diminished response indicates small fiber involvement.
B. Manual Tests
Ninhydrin Sweat Test
Assess sweat gland function by evaluating sweat-induced color change; abnormal in autonomic involvement.Monofilament Test
Use a 10 g monofilament to test pressure sensation on the foot.Two-Point Discrimination
Determine minimum distinguishable distance between two points on the skin.Point Localization
Touch skin and have the patient point to the spot; errors indicate sensory deficits.Temperature Discrimination
Use warm and cold rods to test small fiber function.Tactile Localization
Assess ability to identify where on the body they are touched.Graphesthesia
Trace a number on the palm; inability to recognize suggests cortical vs. peripheral involvement.Stereognosis
Place an object in the hand; inability to identify by touch suggests higher-order dysfunction.
C. Laboratory & Pathological Tests
Anti-GD1b Antibody Assay
Serum immunoassay for IgM/IgG antibodies targeting GD1b disialosyl moieties.Comprehensive Autoimmune Panel
ANA, RF, and other autoantibodies to rule out overlapping syndromes.Serum Protein Electrophoresis
Identify monoclonal gammopathies associated with neuropathies.Vitamin B12 and Folate Levels
Exclude deficiencies that mimic neuropathic ataxia.Thyroid Function Tests
Hypothyroidism can contribute to neuropathy.HIV and Hepatitis Serology
Screen for chronic infections linked to neuropathies.CSF Analysis
Elevated protein with normal cell count (“albuminocytologic dissociation”) supports immune neuropathy.Nerve Biopsy
Histology may show segmental demyelination, inflammatory infiltrates, or axonal loss.
D. Electrodiagnostic Tests
Nerve Conduction Studies (NCS)
Measure conduction velocity and amplitude; slowed speeds indicate demyelination.Sensory Nerve Action Potential (SNAP)
Quantify sensory fiber function; reduced amplitudes in affected nerves.Motor Nerve Conduction
Evaluate motor fibers; may show mild slowing if motor involvement occurs.F-Wave Studies
Test proximal conduction; prolonged latencies suggest demyelination.H-Reflex
Assess reflex arc integrity, often prolonged in sensory neuropathies.Somatosensory Evoked Potentials (SSEPs)
Evaluate central sensory pathways; abnormal in severe cases.Autonomic Reflex Screen
Evaluate heart rate variability and blood pressure responses to tilt-table testing.Quantitative Sensory Testing (QST)
Computerized assessment of vibratory and thermal thresholds.
E. Imaging Tests
MRI of the Spine
Exclude structural lesions; may show nerve root enhancement with gadolinium.MRI of the Brain
Rule out cerebellar or central causes of ataxia.High-Resolution Nerve Ultrasound
Detect nerve enlargement or structural changes.PET–CT Scan
Identify occult malignancies in paraneoplastic cases.Gadolinium-Enhanced MRI of Plexus
Visualize inflammatory changes in brachial or lumbosacral plexus.Doppler Ultrasound of Vessels
Rule out vascular causes of neuropathy.CT Myelography
In rare cases, detect cerebrospinal fluid leaks or nerve root compression.Whole-Body MRI
Screen for granulomatous or infiltrative diseases affecting multiple nerves.
Non-Pharmacological Treatments
In sensory ataxic neuropathies, multi-modal rehabilitation can improve balance, coordination, strength, and quality of life. Below are 30 evidence-informed approaches.
Balance and Gait Training
Description: Supervised exercises using foam pads, balance boards, and gait belts.
Purpose: Enhance proprioception and stability.
Mechanism: Repeated weight-shifting and perturbation challenges neuroplastic adaptations in cerebellar and spinal circuits.
Proprioceptive Neuromuscular Facilitation (PNF)
Description: Assisted diagonal movement patterns.
Purpose: Reinforce sensory feedback loops.
Mechanism: Stimulates muscle spindles and Golgi tendon organs to improve joint position sense.
Tandem Walking Drills
Description: Heel-to-toe walking along a straight line or beam.
Purpose: Challenge dynamic postural control.
Mechanism: Forces central recalibration of vestibulospinal pathways.
Weighted Vest Training
Description: Light weights worn over the torso during stance exercises.
Purpose: Increase sensory input from trunk and lower limbs.
Mechanism: Augments proprioceptive signals to the cerebellum.
Transcutaneous Electrical Nerve Stimulation (TENS)
Description: Low-frequency currents applied to sensory nerves of the feet or legs.
Purpose: Reduce neuropathic pain and enhance sensation.
Mechanism: Gate-control of pain and upregulation of endogenous endorphins.
Neuromuscular Electrical Stimulation (NMES)
Description: Stimulates motor nerves of weakened distal muscles.
Purpose: Prevent atrophy and improve muscle recruitment.
Mechanism: Induced muscle contractions strengthen peripheral motor units.
Vibration Therapy
Description: Standing on a low-frequency vibrating platform.
Purpose: Enhance lower-limb proprioception and muscle activation.
Mechanism: Stimulates Ia afferents, improving reflexive muscle tone.
Hydrotherapy
Description: Aquatic balance exercises in waist-deep warm water.
Purpose: Safely challenge balance without fall risk.
Mechanism: Buoyancy reduces weight-bearing, while water resistance trains stabilizers.
Stationary Cycling with Eyes Closed
Description: Low-resistance cycling without visual cues.
Purpose: Intensify reliance on somatosensory feedback.
Mechanism: Reinforces spinal central pattern generators.
Yoga-Based Balance Poses
Description: Tree pose, warrior III with hand support.
Purpose: Integrate mind-body awareness.
Mechanism: Slow isometric holds refine joint-position sense.
Pilates Core Strengthening
Description: Mat-based hip and trunk stabilization exercises.
Purpose: Improve postural alignment and proximal control.
Mechanism: Engages deep trunk muscles, enhancing central stability.
Mindfulness-Based Stress Reduction
Description: Guided meditation focusing on body scan.
Purpose: Reduce anxiety associated with gait insecurity.
Mechanism: Lowers sympathetic overactivity, which can exacerbate neuropathic symptoms.
Biofeedback Training
Description: Real-time visual/auditory feedback of muscle activity.
Purpose: Teach voluntary control over proprioceptive input.
Mechanism: Enhances cortical mapping of sensory signals.
Cognitive Re-Training
Description: Dual-task exercises combining math or memory with balance tasks.
Purpose: Improve attention and coordination under load.
Mechanism: Strengthens fronto-cerebellar networks.
Educational Self-Management Workshops
Description: Group sessions on risk-reduction, home modifications, and energy conservation.
Purpose: Empower patients to prevent falls and fatigue.
Mechanism: Provides knowledge and behavioral strategies to maintain safety.
Pharmacological Treatments
Most therapies aim at immunomodulation or symptomatic relief.
Intravenous Immunoglobulin (IVIG)
Class: Immunomodulator
Dosage: 2 g/kg over 2–5 days monthly
Timing: Every 4–6 weeks
Side effects: Headache, aseptic meningitis, thromboembolism
Rituximab
Class: Anti-CD20 monoclonal antibody
Dosage: 375 mg/m² weekly × 4 doses
Timing: Repeat every 6 months as needed
Side effects: Infusion reactions, infection risk profiles.wustl.edu
Plasmapheresis
Class: Apheresis therapy
Dosage: 5 exchanges over 10–14 days
Timing: May repeat every 2–3 months
Side effects: Hypotension, bleeding risks
Prednisone
Class: Corticosteroid
Dosage: 1 mg/kg daily, taper over weeks
Timing: Based on clinical response
Side effects: Weight gain, osteoporosis
Cyclophosphamide
Class: Alkylating agent
Dosage: 500 mg/m² IV monthly
Timing: 6–12 cycles
Side effects: Hemorrhagic cystitis, marrow suppression
Azathioprine
Class: Purine analog immunosuppressant
Dosage: 2–3 mg/kg PO daily
Timing: Long-term maintenance
Side effects: Leukopenia, hepatotoxicity
Mycophenolate Mofetil
Class: Antimetabolite
Dosage: 1 g PO twice daily
Timing: Maintenance therapy
Side effects: GI upset, infection risk
Plasma-Rich Protein (PRP) Injections
Class: Biological agent
Dosage: 3 injections at 2-week intervals
Timing: Repeat if relapse
Side effects: Local pain, rare infection
Gabapentin
Class: Anticonvulsant (neuropathic analgesic)
Dosage: 300 mg PO TID, titrate to 3600 mg/day
Timing: Daily for neuropathic pain
Side effects: Sedation, dizziness
Pregabalin
Class: Gabapentinoid
Dosage: 75 mg PO BID, up to 600 mg/day
Timing: Daily
Side effects: Edema, weight gain
Duloxetine
Class: SNRI
Dosage: 30–60 mg PO daily
Timing: Daily
Side effects: Nausea, insomnia
Amitriptyline
Class: Tricyclic antidepressant
Dosage: 10–75 mg PO nightly
Timing: Bedtime
Side effects: Anticholinergic effects
Venlafaxine
Class: SNRI
Dosage: 37.5–150 mg PO daily
Timing: Daily
Side effects: Hypertension
Topiramate
Class: Antiepileptic
Dosage: 25 mg PO BID, up to 200 mg/day
Timing: Daily
Side effects: Cognitive slowing
Metformin (in diabetic patients)
Class: Biguanide
Dosage: 500 mg PO BID
Timing: Daily
Side effects: GI upset
Alpha-lipoic Acid
Class: Antioxidant
Dosage: 600 mg PO daily
Timing: Daily
Side effects: Rare GI upset
Vitamin B12 (Methylcobalamin)
Class: Vitamin
Dosage: 1000 µg IM monthly
Timing: Monthly
Side effects: Very well tolerated
Vitamin D3
Class: Vitamin
Dosage: 1000–2000 IU PO daily
Timing: Daily
Side effects: Hypercalcemia (rare)
Omega-3 Fatty Acids
Class: Dietary lipid
Dosage: 1–2 g EPA/DHA daily
Timing: Daily
Side effects: Fishy aftertaste
Coenzyme Q10
Class: Mitochondrial cofactor
Dosage: 100–300 mg PO daily
Timing: Daily
Side effects: Well tolerated
Dietary Molecular Supplements
Acetyl-L-Carnitine (500 mg PO BID)
Function: Supports mitochondrial fatty-acid oxidation
Mechanism: Enhances neuronal energy metabolism
Alpha-Lipoic Acid (600 mg PO daily)
Function: Antioxidant scavenger
Mechanism: Reduces oxidative nerve damage
Benfotiamine (300 mg PO BID)
Function: Thiamine prodrug for nerve health
Mechanism: Prevents advanced glycation end products
N-Acetylcysteine (600 mg PO BID)
Function: Glutathione precursor
Mechanism: Detoxifies reactive oxygen species
Curcumin Phytosome (500 mg PO daily)
Function: Anti-inflammatory
Mechanism: Inhibits NF-κB signaling
Resveratrol (250 mg PO daily)
Function: Neuroprotective polyphenol
Mechanism: Activates SIRT1 pathways
Phosphatidylserine (100 mg PO TID)
Function: Membrane stabilizer
Mechanism: Enhances neuronal synaptic function
Magnesium L-Threonate (144 mg elemental Mg PO daily)
Function: Neuromodulator
Mechanism: Improves NMDA receptor function
EGCG (Green Tea Extract) (300 mg PO daily)
Function: Antioxidant, anti-inflammatory
Mechanism: Inhibits pro-inflammatory cytokines
Omega-3 Fish Oil (1–2 g EPA/DHA PO daily)
Function: Anti-inflammatory lipid mediator
Mechanism: Shifts eicosanoid balance toward resolution
Advanced Therapeutic Agents
(Bisphosphonates, Regenerative, Viscosupplementation, Stem Cell)
Alendronate (70 mg PO weekly)
Function: Bisphosphonate for bone health
Mechanism: Osteoclast inhibition (used if osteoporosis from steroids)
Zoledronic Acid (5 mg IV yearly)
Function: Potent bisphosphonate
Mechanism: Inhibits bone resorption
Hyaluronic Acid Injection (2 mL IA monthly)
Function: Viscosupplement for joint comfort
Mechanism: Restores synovial viscosity in neuropathy-related joint stress
Platelet-Rich Plasma (PRP) (3 injections)
Function: Regenerative biologic
Mechanism: Growth factors promote nerve microenvironment repair
Mesenchymal Stem Cell Infusion (1×10^6 cells/kg IV)
Function: Cellular regenerative therapy
Mechanism: Anti-inflammatory cytokine release, trophic support
Autologous Schwann Cell Grafts (Under investigation)
Function: Nerve repair
Mechanism: Supports axonal regrowth
Epidural Hyaluronic Acid (Off-label)
Function: Nerve root gliding
Mechanism: Reduces epidural fibrosis
Growth Hormone Secretagogues (e.g., GHRP-6)
Function: Enhances nerve regeneration
Mechanism: Stimulates IGF-1 release
Neuropilin-1 Inhibitors (Clinical trials)
Function: Blocks inhibitory neural receptors
Mechanism: Promotes axonal sprouting
Exosome Therapy (Investigational)
Function: Nano-vesicle based regeneration
Mechanism: Delivers miRNA and trophic factors to damaged nerves
Surgical Procedures
Nerve Decompression Surgery
Procedure: Release of entrapment sites (e.g., tarsal tunnel)
Benefits: Reduces focal ischemia, improves conduction
Intrathecal Baclofen Pump
Procedure: Catheter implantation for spasticity control
Benefits: Improves gait by reducing lower-limb tone
Tendon Transfer
Procedure: Transfers posterior tibialis to anterior compartment
Benefits: Improves foot drop
Dorsal Column Stimulator
Procedure: Epidural electrode placement
Benefits: Modulates pain and may enhance proprioception
Peripheral Nerve Grafting
Procedure: Autograft of sural nerve to damaged segment
Benefits: Facilitates axonal regeneration
Spinal Cord Stimulator (Trial)
Procedure: Percutaneous electrode trial for refractory pain
Benefits: Long-term neuropathic pain relief
Deep Brain Stimulation (Experimental)
Procedure: Thalamic electrode implant
Benefits: May improve gait initiation
Intraneural Vein Wrapping
Procedure: Wrap radicular veins around nerve root
Benefits: Reduces venous congestion
Tendon Lengthening
Procedure: Gastrocnemius or Achilles tendon lengthening
Benefits: Reduces equinus foot posture
Microneurolysis
Procedure: Internal epineurium dissection
Benefits: Alleviates perineural fibrosis
Prevention Strategies
Early Immunotherapy to halt antibody-mediated injury
Fall-Risk Assessment and home modification
Vitamin D and Calcium Supplementation to prevent steroid-induced osteoporosis
Tight Glycemic Control if diabetic
Smoking Cessation to enhance nerve perfusion
Regular Foot Care to prevent ulcerations
Avoidance of Cold Exposures (cold agglutinins)
Vaccination (e.g., influenza) to prevent triggering infections
Weight Management to reduce joint stress
Stress Reduction Techniques to lower sympathetic overactivity
When to See a Doctor
Seek prompt evaluation if you experience:
Sudden worsening of gait or coordination
New onset ophthalmoplegia (double vision)
Severe neuropathic pain unrelieved by medications
Signs of infection or immunotherapy complications
Respiratory weakness or bulbar symptoms
“Do’s” and “Don’ts”
Do: Keep a daily exercise and balance routine.
Do: Use assistive devices (e.g., walker) as needed.
Do: Schedule regular immunotherapy check-ups.
Do: Maintain a neuropathy-friendly diet rich in B vitamins and antioxidants.
Do: Report any new symptoms early.
Don’t: Ignore fall risks—remove loose rugs and install grab bars.
Don’t: Expose yourself to extreme cold.
Don’t: Skip immunotherapy appointments.
Don’t: Smoke or consume excessive alcohol.
Don’t: Overexert—balance activity with rest.
Frequently Asked Questions (FAQs)
What causes CANDA?
It arises from monoclonal IgM antibodies against disialosyl epitopes on gangliosides, likely via molecular mimicry after infections.Is CANDA hereditary?
No, it is an acquired immune-mediated condition, not inherited.Can CANDA be cured?
There is no cure, but immunotherapies like IVIG and rituximab can stabilize or improve symptoms.How fast does it progress?
Typically slowly over years, but some patients worsen more rapidly.Will I need a walker or wheelchair?
Many manage with canes; others may require more support depending on severity.Are there dietary changes that help?
A balanced diet rich in B vitamins, antioxidants, and omega-3s supports nerve health.Can physical therapy help?
Yes—targeted balance, coordination, and strength training are critical.What side effects do treatments have?
Immunotherapies carry risks of infection, infusion reactions, and bone loss from steroids.How often should I have IVIG?
Usually every 4–6 weeks, based on clinical response and IgM levels.Is exercise safe?
Yes, low-impact, supervised exercise reduces fall risk and improves function.Can cold weather worsen symptoms?
Yes—cold agglutinins may precipitate antibody activity; keep warm.Do infections trigger relapses?
Respiratory or GI infections can exacerbate immune responses and worsen neuropathy.Are stem cell therapies approved?
They remain experimental; consult specialized centers for trials.When should surgery be considered?
Only for focal entrapments or severe secondary deformities (e.g., tendon transfers).Where can I find support?
Contact rare-disease organizations (e.g., NORD) and join patient support groups for CANDA/CANOMAD.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: July 07, 2025.
